Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interprofessional BoNT and Therapy for Spasticity
NCT07160699Not yet recruiting
- Sponsor
- University of Bern
- Start
- Oct 2025
- Primary completion
- Oct 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
Open-label, single-arm trial of botulinum toxin type A in spasticity, sponsored by University of Bern. Primary endpoint: Goal Attainment Scale at 24 weeks. Planned start Oct 2025; status: not yet recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
spasticity
Beyond the preview
Go deeper on NCT07160699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07160699.